NCT06574867

Brief Summary

The REQUEST study aims to evaluate the use of a new wireless monitoring device, called the viQtor solution, on a surgical ward in Catharina Hospital Eindhoven. This device continuously tracks vital signs, such as heart rate, breathing rate, and blood oxygen levels, in patients after surgery. The goal is to see if the viQtor solution can help detect health problems earlier and reduce the workload for nurses by minimizing the need for manual checks. The study will involve 500 patients and will take place over 7 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

August 26, 2024

Last Update Submit

April 30, 2026

Conditions

Keywords

Continuous monitoringPost-operative careVital signsHealthcare technologyWearable medical deviceviQtor solutionRemote monitoring

Outcome Measures

Primary Outcomes (1)

  • Usability of the viQtor Monitoring Solution

    Evaluation of the usability of the viQtor solution based on the System Usability Scale (SUS). The outcome will be measured by the SUS score, with a target score of \>68 indicating acceptable usability.

    8 months

Secondary Outcomes (3)

  • Reduction in Nursing Workload

    8 months

  • Predictive Accuracy of the viQtor Solution

    8 months

  • Implementation Success of the viQtor Solution

    8 months

Other Outcomes (1)

  • Nurse and Physician Adoption of the viQtor Solution

    8 months

Study Arms (1)

Surgical Patients Monitored with viQtor

This group includes adult patients admitted to the surgical ward at Catharina Hospital Eindhoven. Participants in this group will be monitored continuously using the viQtor wearable device to track vital signs such as heart rate, respiratory rate, and blood oxygen saturation during their hospital stay. The focus is on evaluating the implementation, usability, and effectiveness of the viQtor solution in a real-world clinical setting.

Device: viQtor Wearable Monitoring Device

Interventions

The viQtor device is a wearable medical device designed for continuous monitoring of vital signs, including heart rate (PR), respiratory rate (RR), and blood oxygen saturation (SpO2). It is worn on the upper arm and transmits data wirelessly to a cloud-based platform. This device is being evaluated as part of the standard monitoring protocol for post-operative patients in a surgical ward setting.

Surgical Patients Monitored with viQtor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult post-operative patients admitted to the surgical ward at Catharina Hospital Eindhoven. The study will focus on evaluating the feasibility and effectiveness of continuous vital sign monitoring using the viQtor device.

You may qualify if:

  • Adult patients (18 years and older).
  • Patients admitted to the surgical ward at Catharina Hospital Eindhoven.
  • Fluent in Dutch or English.
  • Willingness to participate in the study and to wear the viQtor monitoring device during their hospital stay.

You may not qualify if:

  • Patients with cognitive impairments.
  • Patients with allergies to metal or plastics.
  • Patients with significant deformities, swelling, irritation, degenerative changes, or edema of the upper arm.
  • Patients with implanted cardiac pacemakers, internal cardioverter defibrillators, or chronic resynchronization therapy devices.
  • Patients at risk of vascular compromise of the arm on which the device will be placed.
  • Patients with conditions that contraindicate the use of a blood pressure cuff or similar devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catharina Hospital Eindhoven

Eindhoven, North Brabant, 5623EJ, Netherlands

Location

Related Publications (2)

  • Jerry EE, Bouwman ARA, van Esch EMG, Richardson R, Nienhuijs SW. Remote Monitoring With a Reusable Device Upon Implementation on a Surgical Department (REQUEST Trial). World J Surg. 2026 Mar;50(3):676-683. doi: 10.1002/wjs.70261. Epub 2026 Feb 11.

  • Jerry EE, Bouwman AR, Nienhuijs SW. Remote Monitoring by ViQtor Upon Implementation on a Surgical Department (REQUEST-Trial): Protocol for a Prospective Implementation Study. JMIR Res Protoc. 2025 Jul 3;14:e70707. doi: 10.2196/70707.

Study Officials

  • Simon S.W. Nienhuijs, Dr. PHD.

    Catharina Ziekenhuis Eindhoven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Drs.

Study Record Dates

First Submitted

August 26, 2024

First Posted

August 28, 2024

Study Start

October 1, 2024

Primary Completion

July 31, 2025

Study Completion

December 1, 2025

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to concerns about patient privacy and confidentiality. The data collected includes sensitive health information, and sharing it could risk breaching participant anonymity. Additionally, the study's data use agreements and local regulations do not permit the sharing of IPD with external researchers.

Locations